Communicating treatment effectiveness in the context of chronic disease processes

References

• Buch P, Rasmussen S, Abildstrom SZ, Kober L, Carlsen J, Torp-Pedersen C. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years. Eur. Heart J.26(2), 145–152 (2005)
   PubMed Web of Science ®Google Scholar
• van Hout BA, Simoons ML. Cost–effectiveness of HMG coenzyme reductase inhibitors; whom to treat? Eur. Heart J.22(9), 751–761 (2001).
   PubMed Web of Science ®Google Scholar
• Christensen PM, Brosen K, Brixen K, Kristiansen IS. Expressing effects of osteoporosis interventions in terms of postponing of fractures. Eur. J. Clin. Pharmacol.58(9), 629–633 (2002).
   Google Scholar
• Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. Med.318(26), 1728–1733 (1988).
   PubMed Web of Science ®Google Scholar
• McAlister FA, Straus SE, Guyatt GH, Haynes RB. Users’ guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA21, 2829–2836 (2000).
   Google Scholar
• Misselbrook D, Armstrong D. Thinking about risk. Can doctors and patients talk the same language? Fam. Pract.19(1), 1–2 (2002).
   PubMedGoogle Scholar
• Brown G, Albers JJ, Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med.323(19), 1289–1298 (1990).
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Ross PD, Black D et al. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum.42(6), 1246–1254 (1999).
   PubMed Web of Science ®Google Scholar
• Malenka DJ, Baron JA, Johansen S, Wahrenberger JW, Ross JM. The framing effect of relative and absolute risk. J. Gen. Intern. Med.8(10), 543–548 (1993).
   PubMed Web of Science ®Google Scholar
• Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions Am. J. Med.92(2), 121–124 (1992).
   PubMed Web of Science ®Google Scholar
• Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. Br. Med. J.311(7012), 1056–1059 (1995).
   PubMed Web of Science ®Google Scholar
• Olsen JA, Richardson J, Dolan P, Menzel P. The moral relevance of personal characteristics in setting health care priorities. Soc. Sci. Med.57, 1163–1172 (2003).
   Google Scholar
• Dolan P, Shaw R, Tsuchiya A, Williams A. QALY maximisation and people’s preferences: a methodological review of the literature. Health Econ.14, 197–208 (2005).
   PubMed Web of Science ®Google Scholar
• Wagstaff A. QALYs and the equity-efficiency trade-off. In: Cost-Benefit Analysis (2nd Edition). Laylard R, Glaister S (Eds). Cambridge University Press, Cambridge, UK, 428–447 (1994).
   Google Scholar
• Olsen JA. Persons vs years: two ways of eliciting implicit weights. Health Econ.3, 39–46 (1994).
   Google Scholar
• Johannesson M, Gerdham U-G. A note on the estimation of the equity-efficiency trade-off for QALYs. J. Health Econ.15, 359–368 (1996).
   PubMed Web of Science ®Google Scholar
• Gyrd-Hansen D. Investigating the social value of health changes. J. Health Econ.23, 1101–1116 (2004).
   PubMed Web of Science ®Google Scholar
• Rodgriguez-Miguez E, Pinto-Prades J-L. Measuring the social importance of concentration or dispersion of individual health benefits. Health Econ.11, 43–53 (2002).
   Google Scholar
• Olsen JA. Eliciting distributive preferences for health: some problems and a few lessons. J. Health Econ.19, 541–550 (2000).
   Google Scholar
• Gafni A. The standard gamble method: what is being measured and how is it interpreted. Health Serv. Res.29(2), 207–224 (1994).
   PubMed Web of Science ®Google Scholar
• Gyrd-Hansen D, Søgaard J. Discounting life-years: whither time preference? Health Econ..7, 121–127 (1998).
   Google Scholar
• McNeil BJ, Weichselbaum R, Pauker S. Fallacy of the five-year survival in lung cancer. N. Engl. J. Med.299, 1397–1401 (1978).
   PubMed Web of Science ®Google Scholar
• Bleichrodt H, Eeckhoudt L. Willingness to pay for reduction in health risks when probabilities are distorted. Health Econ.15, 211–214 (2006).
   Google Scholar
• Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J. Clin. Epidemiol.55(9), 888–902 (2002).
   PubMed Web of Science ®Google Scholar
• Wright JC, Weinstein MC. Gains in life expectancy from medical interventions – standardizing data on outcomes. N. Engl. J. Med.339(6), 380–386 (1998).
   PubMed Web of Science ®Google Scholar
• Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost–effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N. Engl. J. Med.336(5), 332–336 (1997).
   PubMed Web of Science ®Google Scholar
• Selmer RM, Kristiansen IS, Haglerod A et al. Cost and health consequences of reducing the population intake of salt. J. Epidemiol. Community Health54(9), 697–702 (2000).
   PubMedGoogle Scholar
• Hatziandreu EI, Koplan JP, Weinstein MC, Caspersen CJ, Warner KE. A cost–effectiveness analysis of exercise as a health promotion activity. Am. J. Public Health78, 1417–1421 (1988).
   PubMed Web of Science ®Google Scholar
• Sackett DL. On some clinically useful measures of the effect of treatment. Evid. Based Med.1, 37–38 (1996).
   Google Scholar
• McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann. Intern. Med.126(9), 712–720 (1997).
   PubMed Web of Science ®Google Scholar
• Riegelman R, Schroth WS. Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms. Med. Decis. Making13(3), 247–252 (1993).
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Pignone M, Lewis CL. A randomized comparison of patients’ understanding of number needed to treat and other common risk reduction formats. J. Gen. Int. Med.18(1), 884–892 (2003).
   PubMed Web of Science ®Google Scholar
• Christensen PM, Brosen K, Brixen K, Andersen M, Kristiansen IS. A randomized trial of laypersons’ perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin. Ther.25(10), 2575–2285 (2003).
   PubMed Web of Science ®Google Scholar
• Halvorsen PA, Kristiansen IS. Decisions on drug therapies by numbers needed to treat: a randomized trial. Arch. Intern. Med.165(10), 1140–1146 (2005).
   PubMedGoogle Scholar
• Nexoe J, Kristiansen IS, Gyrd-Hansen D, Nielsen JB. Influence of number needed to treat, costs and outcome on preferences for a preventive drug. Fam. Pract.22(1), 126–131 (2005).
   PubMed Web of Science ®Google Scholar
• Nexoe J, Gyrd-Hansen D, Kragstrup J, Kristiansen IS, Nielsen JB. Danish GPs’ perception of disease risk and benefit of intervention. Fam. Prac.9, 3–6 (2002).
   Google Scholar
• Halvorsen PA, Kristiansen IS, Aasland OG, Forde OH. Medical doctors’ perception of the “number needed to treat” (NNT). A survey of doctors’ recommendations for two therapies with different NNT. Scand. J. Prim. Health Care21(3), 162–166 (2003).
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Pignone M. Numeracy and the medical student's ability to interpret data. Eff. Clin. Pract.5(1), 35–40 (2002).
   PubMedGoogle Scholar
• Kristiansen IS. Communicating effect of risk interventions in terms of postponement of adverse effect. Med. Decis. Making20, 422 (2004).
   Google Scholar
• Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. Br. Med. J.327(7417), 741–744 (2003).
   PubMed Web of Science ®Google Scholar